2021 Interim Award Funding Policy

The Department of Health and Human Services (HHS), including NIH, Continuing Appropriations Act, 2021 and Other Extensions Act (Public Law 116-159) signed by President Trump on October 1, 2020. This Act (CR) continues government operations through December 11, 2020 at the FY 2020 enacted level, with no reduction.

NIDDK extramural research is organized into 3 programmatic divisions: 1) Diabetes, Endocrinology, and Metabolic Diseases; 2) Digestive Diseases and Nutrition; and 3) Kidney, Urologic, and Hematologic Diseases.

Until FY 2021 appropriations are enacted, NIH will issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). See NOT-OD-20-068: Notice of Fiscal Policies in Effect for FY 2020 for details.

  • NIDDK will announce additional details regarding its interim FY 2021 funding policy, including details regarding funding of competing grant applications as information becomes available.